Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Organon Says Nduvra Cream Gets Canada Approval for Atopic Dermatitis

Organon Says Nduvra Cream Gets Canada Approval for Atopic Dermatitis

MT newswireMT newswire2026/09/28 13:24
09:24 AM EDT, 09/28/2026 (MT Newswires) -- Organon (OGN) subsidiary Organon Canada said Monday it has received approval for Nduvra tapinarof cream 1% to treat moderate to severe atopic dermatitis in adults and children at least two years old. Nduvra is a steroid-free topical treatment and the new indication marks the second approval for the cream in Canada, Organon Canada said.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

US Stock Market Movement | Nvidia-backed AI pharmaceutical company Iambic Therapeutics (IAM.US) debuts on Nasdaq, surging over 11% after opening

As of press time, the stock is up more than 11%, trading at $17.77.

智通财经•2026/10/15 16:26

US Stock Market Movement | 3D Printing Materials Supplier Amaero (AMRO.US) Debuts on US Stock Market, Trading Halt Triggered After Opening

Amaero, a manufacturer specializing in titanium and refractory metal powders for 3D printing in the defense and aerospace sectors, has gone public on the US stock market.

智通财经•2026/10/15 16:21
US Stock Market Movement | 3D Printing Materials Supplier Amaero (AMRO.US) Debuts on US Stock Market, Trading Halt Triggered After Opening